ArticleAntibodies (Basel, Switzerland)2025
Investigation of Antibody Pharmacokinetics in Male Reproductive System and Its Characterization Using a Translational PBPK Model.
Sree Ojili, Dhaval K Shah
Abstract read
In one paragraphArticle in Antibodies (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
2 authors.
Sree OjiliDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY 14214-8033, USA.
Dhaval K ShahDepartment of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, The State University of New York at Buffalo, Buffalo, NY 14214-8033, USA.ORCID 0000-0002-0723-6206 Funding
Enhancement of ADC selectivity by inverse targeting: Mechanistic studies and optimizationR01CA256928 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BALTHASAR, JOSEPH P · 2021 to 2025
$1.8MPharmacokinetic strategies to increase monoclonal antibody uptake, distribution, and efficacy for treatment of solid tumorsR01CA246785 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BALTHASAR, JOSEPH P, SHAH, DHAVAL K · 2020 to 2024
$1.8MPharmacokinetic / Pharmacodynamic Optimization of ADC Therapy for Acute Myeloid LeukemiaR01CA275967 · NCI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI Joseph P Balthasar, Dhaval K Shah · 2023 to 2026
$1.7MTranslational Systems Pharmacokinetic Models of Novel Anticancer BiologicsR01GM114179 · NIGMS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI SHAH, DHAVAL K · 2015 to 2019
$1.7MProposal for Administrative supplement to Purchase NanoSight ProR01GM146097 · NIGMS · UNIVERSITY OF ALABAMA IN TUSCALOOSA · PI Ravikumar N Majeti, Dhaval K Shah · 2023 to 2026
$1.6MModulation of antigen pharmacokinetics with pH dependent antibodyR21AI138195 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI PARK, SHELDON · 2018 to 2019
$425kcenter for protein therapeutics NANational Institute of Allergy and Infectious Diseases AI138195NCI NIH HHS R01 CA246785NCI NIH HHS R01CA246785, R01CA256928, and R01CA275967NCI NIH HHS R01 CA256928NCI NIH HHS R01 CA275967NIAID NIH HHS R21 AI138195NIGMS NIH HHS GM114179, GM146097NIGMS NIH HHS R01 GM114179NIGMS NIH HHS R01 GM146097
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antibodyclinical translationmale reproductive systemPBPK modellingpharmacokinetics
Identifiers
PMID39982232
PMCPMC11843977
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390